TreeWAS – Variant ID: rs6028945

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.984	0.016
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.986	0.014
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.987	0.013
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.987	0.013
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.990	0.010
T43.9 Psychotropic drug, unspecified	0.000	0.990	0.010
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.990	0.010
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.990	0.010
T43.2 Other and unspecified antidepressants	0.000	0.990	0.010
T43.6 Psychostimulants with abuse potential	0.000	0.990	0.010
Z99.3 Dependence on wheelchair	0.000	0.994	0.006
I95.1 Orthostatic hypotension	0.000	0.994	0.006
E87.7 Fluid overload	0.006	0.994	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.995	0.005
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.996	0.004
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.996	0.004
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
N50.1 Vascular disorders of male genital organs	0.000	0.996	0.004
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.996	0.004
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.996	0.004
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.996	0.004
C54.1 Endometrium	0.000	0.996	0.004
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.996	0.004
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.996	0.004
T40.4 Other synthetic narcotics	0.000	0.996	0.004
M46.92 Inflammatory spondylopathy, unspecified (Cervical region)	0.000	0.996	0.004
T83.0 Mechanical complication of urinary (indwelling) catheter	0.000	0.996	0.004
C45.0 Mesothelioma of pleura	0.000	0.996	0.004
Z48.8 Other specified surgical follow-up care	0.000	0.996	0.004
T36 Poisoning by systemic antibiotics	0.000	0.996	0.003
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
O13 Gestational [pregnancy-induced] hypertension without significant proteinuria	0.000	0.996	0.004
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.996	0.003
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.997	0.003
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.997	0.003
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.997	0.003
T42.3 Barbiturates	0.000	0.997	0.003
T42.2 Succinimides and oxazolidinediones	0.000	0.997	0.003
T50.8 Diagnostic agents	0.000	0.997	0.003
T50.7 Analeptics and opioid receptor antagonists	0.000	0.997	0.003
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.997	0.003
T50.5 Appetite depressants	0.000	0.997	0.003
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.997	0.003
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.997	0.003
T50.1 Loop [high-ceiling] diuretics	0.000	0.997	0.003
T50.0 Mineralocorticoids and their antagonists	0.000	0.997	0.003
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.000	0.997	0.003
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.997	0.003
T40.8 Lysergide [LSD]	0.000	0.997	0.003
T40.7 Cannabis (derivatives)	0.000	0.997	0.003
T40.5 Cocaine	0.000	0.997	0.003
T40.3 Methadone	0.000	0.997	0.003
T40.1 Heroin	0.000	0.997	0.003
T40.0 Opium	0.000	0.997	0.003
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.997	0.003
T38.9 Other and unspecified hormone antagonists	0.000	0.997	0.003
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.997	0.003
T38.7 Androgens and anabolic congeners	0.000	0.997	0.003
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.997	0.003
T38.5 Other oestrogens and progestogens	0.000	0.997	0.003
T38.4 Oral contraceptives	0.000	0.997	0.003
T38.2 Antithyroid drugs	0.000	0.997	0.003
T38.1 Thyroid hormones and substitutes	0.000	0.997	0.003
T38.0 Glucocorticoids and synthetic analogues	0.000	0.997	0.003
T40.2 Other opioids	0.000	0.997	0.003
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.997	0.003
T45.8 Other primarily systemic and haematological agents	0.000	0.997	0.003
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.997	0.003
T45.6 Fibrinolysis-affecting drugs	0.000	0.997	0.003
T45.4 Iron and its compounds	0.000	0.997	0.003
T45.3 Enzymes, not elsewhere classified	0.000	0.997	0.003
T45.2 Vitamins, not elsewhere classified	0.000	0.997	0.003
T40.6 Other and unspecified narcotics	0.000	0.997	0.003
T50.4 Drugs affecting uric acid metabolism	0.000	0.997	0.003
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.003	0.997	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.997	0.003
C78.8 Secondary malignant neoplasm of other and unspecified digestive organs	0.003	0.997	0.000
T42.4 Benzodiazepines	0.000	0.997	0.003
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.997	0.003
T45.5 Anticoagulants	0.000	0.997	0.003
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.997	0.003
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.997	0.003
T37.5 Antiviral drugs	0.000	0.997	0.003
T37.4 Anthelminthics	0.000	0.997	0.003
T37.3 Other antiprotozoal drugs	0.000	0.997	0.003
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.997	0.003
T37.1 Antimycobacterial drugs	0.000	0.997	0.003
T37.0 Sulphonamides	0.000	0.997	0.003
T41.5 Therapeutic gases	0.000	0.997	0.003
T41.4 Anaesthetic, unspecified	0.000	0.997	0.003
T41.3 Local anaesthetics	0.000	0.997	0.003
T41.2 Other and unspecified general anaesthetics	0.000	0.997	0.003
T41.1 Intravenous anaesthetics	0.000	0.997	0.003
T41.0 Inhaled anaesthetics	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.997	0.003
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.997	0.003
T48.5 Anti-common-cold drugs	0.000	0.997	0.003
T48.4 Expectorants	0.000	0.997	0.003
T48.3 Antitussives	0.000	0.997	0.003
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.997	0.003
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.997	0.003
T48.0 Oxytocic drugs	0.000	0.997	0.003
T49.9 Topical agent, unspecified	0.000	0.997	0.003
T49.8 Other topical agents	0.000	0.997	0.003
T49.7 Dental drugs, topically applied	0.000	0.997	0.003
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.997	0.003
T49.5 Ophthalmological drugs and preparations	0.000	0.997	0.003
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.997	0.003
T49.3 Emollients, demulcents and protectants	0.000	0.997	0.003
T49.2 Local astringents and local detergents	0.000	0.997	0.003
T49.1 Antipruritics	0.000	0.997	0.003
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.997	0.003
I65.2 Occlusion and stenosis of carotid artery	0.000	0.997	0.003
M46.96 Inflammatory spondylopathy, unspecified (Lumbar region)	0.000	0.997	0.003
T36.9 Systemic antibiotic, unspecified	0.000	0.997	0.003
T36.8 Other systemic antibiotics	0.000	0.997	0.003
T36.7 Antifungal antibiotics, systemically used	0.000	0.997	0.003
T36.6 Rifamycins	0.000	0.997	0.003
T36.5 Aminoglycosides	0.000	0.997	0.003
T36.4 Tetracyclines	0.000	0.997	0.003
T36.3 Macrolides	0.000	0.997	0.003
T36.2 Chloramphenicol group	0.000	0.997	0.003
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.997	0.003
F40.2 Specific (isolated) phobias	0.000	0.997	0.003
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.000	0.997	0.003
M46.9 Inflammatory spondylopathy, unspecified	0.000	0.997	0.003
C67.9 Bladder, unspecified	0.000	0.997	0.003
O20.9 Haemorrhage in early pregnancy, unspecified	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
T42.1 Iminostilbenes	0.000	0.997	0.003
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.997	0.003
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.997	0.003
T47.7 Emetics	0.000	0.997	0.003
T47.6 Antidiarrhoeal drugs	0.000	0.997	0.003
T47.5 Digestants	0.000	0.997	0.003
T47.4 Other laxatives	0.000	0.997	0.003
T47.3 Saline and osmotic laxatives	0.000	0.997	0.003
T47.2 Stimulant laxatives	0.000	0.997	0.003
T47.0 Histamine H(2)-receptor antagonists	0.000	0.997	0.003
T36.0 Penicillins	0.000	0.997	0.002
C67 Malignant neoplasm of bladder	0.000	0.997	0.003
Z36 Antenatal screening	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.000	0.997	0.002
M47.26 Other spondylosis with radiculopathy (Lumbar region)	0.003	0.997	0.000
C81.9 Hodgkin's disease, unspecified	0.000	0.997	0.003
Z36.0 Antenatal screening for chromosomal anomalies	0.003	0.997	0.000
H43.3 Other vitreous opacities	0.000	0.997	0.003
L08.9 Local infection of skin and subcutaneous tissue, unspecified	0.000	0.997	0.003
C45 Mesothelioma	0.000	0.997	0.003
M13.91 Arthritis, unspecified (Shoulder region)	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.997	0.002
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.997	0.002
T46.7 Peripheral vasodilators	0.000	0.997	0.002
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.002
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.002
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.997	0.002
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.997	0.002
C67.3 Anterior wall of bladder	0.000	0.998	0.002
C67.4 Posterior wall of bladder	0.000	0.998	0.002
C67.8 Overlapping lesion of bladder	0.000	0.998	0.002
C67.6 Ureteric orifice	0.000	0.998	0.002
Z36.2 Other antenatal screening based on amniocentesis	0.002	0.998	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.998	0.002
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.998	0.002
K25.3 Acute without haemorrhage or perforation	0.000	0.998	0.002
C45.9 Mesothelioma, unspecified	0.000	0.998	0.002
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.000	0.998	0.002
M46.98 Inflammatory spondylopathy, unspecified (Sacral and sacrococcygeal region)	0.000	0.998	0.002
M46.95 Inflammatory spondylopathy, unspecified (Thoracolumbar region)	0.000	0.998	0.002
M46.94 Inflammatory spondylopathy, unspecified (Thoracic region)	0.000	0.998	0.002
M46.93 Inflammatory spondylopathy, unspecified (Cervicothoracic region)	0.000	0.998	0.002
M46.91 Inflammatory spondylopathy, unspecified (Occipito-atlanto-axial region)	0.000	0.998	0.002
M46.90 Inflammatory spondylopathy, unspecified (Multiple sites in spine)	0.000	0.998	0.002
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.998	0.002
L40.0 Psoriasis vulgaris	0.002	0.998	0.000
Z36.1 Antenatal screening for raised alphafetoprotein level	0.002	0.998	0.000
Z36.8 Other antenatal screening	0.002	0.998	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.002	0.998	0.000
Z36.9 Antenatal screening, unspecified	0.002	0.998	0.000
C54 Malignant neoplasm of corpus uteri	0.000	0.998	0.002
C67.7 Urachus	0.000	0.998	0.002
C67.1 Dome of bladder	0.000	0.998	0.002
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.998	0.002
M46.97 Inflammatory spondylopathy, unspecified (Lumbosacral region)	0.000	0.998	0.002
Z36.5 Antenatal screening for isoimmunisation	0.002	0.998	0.000
C45.7 Mesothelioma of other sites	0.000	0.998	0.002
C45.2 Mesothelioma of pericardium	0.000	0.998	0.002
C45.1 Mesothelioma of peritoneum	0.000	0.998	0.002
H43.1 Vitreous haemorrhage	0.000	0.998	0.002
I70.2 Atherosclerosis of arteries of the extremities	0.002	0.998	0.000
C67.5 Bladder neck	0.000	0.998	0.002
N39.8 Other specified disorders of urinary system	0.002	0.998	0.000
M18 Arthrosis of first carpometacarpal joint	0.000	0.998	0.002
C67.0 Trigone of bladder	0.000	0.998	0.002
I22.1 Subsequent myocardial infarction of inferior wall	0.002	0.998	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.998	0.002
M18.1 Other primary arthrosis of first carpometacarpal joint	0.000	0.998	0.002
C66 Malignant neoplasm of ureter	0.000	0.998	0.002
C54.9 Corpus uteri, unspecified	0.000	0.998	0.002
H43 Disorders of vitreous body	0.000	0.998	0.002
D06.9 Cervix, unspecified	0.000	0.998	0.002
Q63.0 Accessory kidney	0.000	0.998	0.002
C54.8 Overlapping lesion of corpus uteri	0.000	0.998	0.002
C54.3 Fundus uteri	0.000	0.998	0.002
C54.2 Myometrium	0.000	0.998	0.002
C54.0 Isthmus uteri	0.000	0.998	0.002
F31.9 Bipolar affective disorder, unspecified	0.000	0.998	0.002
K55.2 Angiodysplasia of colon	0.002	0.998	0.000
C67.2 Lateral wall of bladder	0.000	0.998	0.002
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.998	0.002
Y79.2 Prosthetic and other implants, materials and accessory devices	0.002	0.998	0.000
H43.9 Disorder of vitreous body, unspecified	0.000	0.998	0.002
Z91.6 Personal history of other physical trauma	0.002	0.998	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.002	0.998	0.000
M24.17 Other articular cartilage disorders (Ankle and foot)	0.000	0.998	0.002
D03.5 Melanoma in situ of trunk	0.000	0.998	0.002
Z42.3 Follow-up care involving plastic surgery of upper extremity	0.000	0.998	0.002
H33.5 Other retinal detachments	0.000	0.998	0.002
M18.5 Other secondary arthrosis of first carpometacarpal joint	0.000	0.998	0.002
M18.4 Other secondary arthrosis of first carpometacarpal joints, bilateral	0.000	0.998	0.002
M18.3 Other posttraumatic arthrosis of first carpometacarpal joint	0.000	0.998	0.002
M18.2 Posttraumatic arthrosis of first carpometacarpal joints, bilateral	0.000	0.998	0.002
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.002	0.998	0.000
H43.0 Vitreous prolapse	0.000	0.998	0.002
K22.6 Gastro-oesophageal laceration-haemorrhage syndrome	0.002	0.998	0.000
Z42.1 Follow-up care involving plastic surgery of breast	0.000	0.998	0.002
M47.2 Other spondylosis with radiculopathy	0.002	0.998	0.000
H60.9 Otitis externa, unspecified	0.000	0.998	0.002
W10.8 Other specified place	0.002	0.998	0.000
A63.0 Anogenital (venereal) warts	0.000	0.998	0.002
C64-C68 Malignant neoplasms of urinary tract	0.000	0.998	0.002
H43.2 Crystalline deposits in vitreous body	0.000	0.998	0.001
D17.0 Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck	0.002	0.998	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.002	0.998	0.000
M13.94 Arthritis, unspecified (Hand)	0.000	0.998	0.002
L81.4 Other melanin hyperpigmentation	0.000	0.998	0.002
Z85.5 Personal history of malignant neoplasm of urinary tract	0.000	0.998	0.002
L40.5 Arthropathic psoriasis	0.001	0.998	0.000
H33.3 Retinal breaks without detachment	0.000	0.999	0.001
J98.4 Other disorders of lung	0.000	0.999	0.001
M47.29 Other spondylosis with radiculopathy (Site unspecified)	0.001	0.999	0.000
M47.28 Other spondylosis with radiculopathy (Sacral and sacrococcygeal region)	0.001	0.999	0.000
M47.25 Other spondylosis with radiculopathy (Thoracolumbar region)	0.001	0.999	0.000
M47.24 Other spondylosis with radiculopathy (Thoracic region)	0.001	0.999	0.000
M47.23 Other spondylosis with radiculopathy (Cervicothoracic region)	0.001	0.999	0.000
M47.21 Other spondylosis with radiculopathy (Occipito-atlanto-axial region)	0.001	0.999	0.000
M47.20 Other spondylosis with radiculopathy (Multiple sites in spine)	0.001	0.999	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.000	0.999	0.001
I22.9 Subsequent myocardial infarction of unspecified site	0.001	0.999	0.000
C78.4 Secondary malignant neoplasm of small intestine	0.001	0.999	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.999	0.001
M47.27 Other spondylosis with radiculopathy (Lumbosacral region)	0.001	0.999	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.000	0.999	0.001
C78.1 Secondary malignant neoplasm of mediastinum	0.001	0.999	0.000
H11.4 Other conjunctival vascular disorders and cysts	0.000	0.999	0.001
H57.1 Ocular pain	0.000	0.999	0.001
L40.3 Pustulosis palmaris et plantaris	0.001	0.999	0.000
I82.8 Embolism and thrombosis of other specified veins	0.000	0.999	0.001
Y89.9 Sequelae of unspecified external cause	0.001	0.999	0.000
C81 Hodgkin's disease	0.000	0.999	0.001
F31.2 Bipolar affective disorder, current episode manic with psychotic symptoms	0.000	0.999	0.001
Q63.1 Lobulated, fused and horseshoe kidney	0.000	0.999	0.001
L40 Psoriasis	0.001	0.999	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.999	0.001
M79.65 Pain in limb (Pelvic region and thigh)	0.001	0.999	0.000
I44.0 Atrioventricular block, first degree	0.001	0.999	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.000	0.999	0.001
M06.99 Rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.999	0.001
C68.9 Urinary organ, unspecified	0.000	0.999	0.001
C68.8 Overlapping lesion of urinary organs	0.000	0.999	0.001
C68.1 Paraurethral glands	0.000	0.999	0.001
C68.0 Urethra	0.000	0.999	0.001
S43.0 Dislocation of shoulder joint	0.001	0.999	0.000
R44.1 Visual hallucinations	0.001	0.999	0.000
R44.0 Auditory hallucinations	0.001	0.999	0.000
G45.4 Transient global amnesia	0.001	0.999	0.000
L91.0 Keloid scar	0.000	0.999	0.001
O24.4 Diabetes mellitus arising in pregnancy	0.000	0.999	0.001
I70.00 Atherosclerosis of aorta (without gangrene)	0.001	0.999	0.000
H43.8 Other disorders of vitreous body	0.000	0.999	0.001
D03 Melanoma in situ	0.000	0.999	0.001
M24.15 Other articular cartilage disorders (Pelvic region and thigh)	0.000	0.999	0.001
C81.7 Other Hodgkin's disease	0.000	0.999	0.001
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.999	0.001
C81.3 Lymphocytic depletion	0.000	0.999	0.001
C81.2 Mixed cellularity	0.000	0.999	0.001
C81.0 Lymphocytic predominance	0.000	0.999	0.001
L40.4 Guttate psoriasis	0.001	0.999	0.000
L40.2 Acrodermatitis continua	0.001	0.999	0.000
L40.1 Generalised pustular psoriasis	0.001	0.999	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.999	0.001
T39.2 Pyrazolone derivatives	0.000	0.999	0.001
Q63 Other congenital malformations of kidney	0.000	0.999	0.001
C81.1 Nodular sclerosis	0.000	0.999	0.001
H21.5 Other adhesions and disruptions of iris and ciliary body	0.001	0.999	0.000
I70.0 Atherosclerosis of aorta	0.001	0.999	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.000	0.999	0.001
H65.9 Nonsuppurative otitis media, unspecified	0.001	0.999	0.000
N28.1 Cyst of kidney, acquired	0.000	0.999	0.001
I70 Atherosclerosis	0.001	0.999	0.000
D03.4 Melanoma in situ of scalp and neck	0.000	0.999	0.001
L81.9 Disorder of pigmentation, unspecified	0.000	0.999	0.001
C78 Secondary malignant neoplasm of respiratory and digestive organs	0.001	0.999	0.000
O20 Haemorrhage in early pregnancy	0.000	0.999	0.001
D03.9 Melanoma in situ, unspecified	0.000	0.999	0.001
D03.8 Melanoma in situ of other sites	0.000	0.999	0.001
D03.1 Melanoma in situ of eyelid, including canthus	0.000	0.999	0.001
D03.0 Melanoma in situ of lip	0.000	0.999	0.001
D44.7 Aortic body and other paraganglia	0.001	0.999	0.000
N04.9 Unspecified	0.001	0.999	0.000
S13.4 Sprain and strain of cervical spine	0.001	0.999	0.000
Z91.8 Personal history of other specified risk-factors, not elsewhere classified	0.001	0.999	0.000
Y79 Orthopaedic devices associated with adverse incidents	0.001	0.999	0.000
I70.01 Atherosclerosis of aorta (with gangrene)	0.001	0.999	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.999	0.001
H44.0 Purulent endophthalmitis	0.000	0.999	0.001
Q63.9 Congenital malformation of kidney, unspecified	0.000	0.999	0.001
Q63.8 Other specified congenital malformations of kidney	0.000	0.999	0.001
Q63.3 Hyperplastic and giant kidney	0.000	0.999	0.001
Q63.2 Ectopic kidney	0.000	0.999	0.001
Z91.0 Personal history of allergy, other than to drugs and biological substances	0.001	0.999	0.000
C65 Malignant neoplasm of renal pelvis	0.000	0.999	0.001
C78.6 Secondary malignant neoplasm of retroperitoneum and peritoneum	0.001	0.999	0.000
H20.1 Chronic iridocyclitis	0.001	0.999	0.000
I70.9 Generalised and unspecified atherosclerosis	0.001	0.999	0.000
I70.8 Atherosclerosis of other arteries	0.001	0.999	0.000
R44.3 Hallucinations, unspecified	0.001	0.999	0.000
L52 Erythema nodosum	0.001	0.999	0.000
C78.3 Secondary malignant neoplasm of other and unspecified respiratory organs	0.001	0.999	0.000
I84.7 Unspecified thrombosed haemorrhoids	0.000	0.999	0.001
Y79.8 Miscellaneous devices, not elsewhere classified	0.001	0.999	0.000
Y79.3 Surgical instruments, materials and devices (including sutures)	0.001	0.999	0.000
Y79.1 Therapeutic (nonsurgical) and rehabilitative devices	0.001	0.999	0.000
Y79.0 Diagnostic and monitoring devices	0.001	0.999	0.000
Z91.2 Personal history of poor personal hygiene	0.001	0.999	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.001	0.999	0.000
I22 Subsequent myocardial infarction	0.001	0.999	0.000
S83.5 Sprain and strain involving (anterior)(posterior) cruciate ligament of knee	0.001	0.999	0.000
V44.5 Driver injured in traffic accident	0.001	0.999	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.000	0.999	0.001
Z48 Other surgical follow-up care	0.000	0.999	0.001
I70.81 Atherosclerosis of other arteries (with gangrene)	0.001	0.999	0.000
I70.80 Atherosclerosis of other arteries (without gangrene)	0.001	0.999	0.000
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.001	0.999	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.001	0.999	0.000
D03.2 Melanoma in situ of ear and external auricular canal	0.000	0.999	0.001
K62.0 Anal polyp	0.001	0.999	0.000
T31.0 Burns involving less than 10% of body surface	0.000	0.999	0.001
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.999	0.001
H71 Cholesteatoma of middle ear	0.001	0.999	0.000
L08 Other local infections of skin and subcutaneous tissue	0.000	0.999	0.001
M46 Other inflammatory spondylopathies	0.000	0.999	0.001
Z91 Personal history of risk-factors, not elsewhere classified	0.001	0.999	0.000
M84.17 Nonunion of fracture [pseudarthrosis] (Ankle and foot)	0.000	0.999	0.001
C78.5 Secondary malignant neoplasm of large intestine and rectum	0.001	0.999	0.000
C91.0 Acute lymphoblastic leukaemia	0.000	0.999	0.001
H49.1 Fourth [trochlear] nerve palsy	0.000	0.999	0.001
H52.3 Anisometropia and aniseikonia	0.001	0.999	0.000
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.000	0.999	0.001
I65.8 Occlusion and stenosis of other precerebral artery	0.000	0.999	0.001
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.000	0.999	0.001
R44.2 Other hallucinations	0.001	0.999	0.000
M13.98 Arthritis, unspecified (Other)	0.000	0.999	0.001
I70.1 Atherosclerosis of renal artery	0.001	0.999	0.000
L08.1 Erythrasma	0.000	0.999	0.001
L08.0 Pyoderma	0.000	0.999	0.001
L40.8 Other psoriasis	0.001	0.999	0.000
M46.8 Other specified inflammatory spondylopathies	0.000	0.999	0.001
M46.5 Other infective spondylopathies	0.000	0.999	0.001
M46.2 Osteomyelitis of vertebra	0.000	0.999	0.001
M46.0 Spinal enthesopathy	0.000	0.999	0.001
S80.0 Contusion of knee	0.000	0.999	0.001
Z91.7 Personal history of female genital mutilation	0.001	0.999	0.000
Z91.4 Personal history of psychological trauma, not elsewhere classified	0.001	0.999	0.000
Z91.3 Personal history of unhealthy sleep-wake schedule	0.001	0.999	0.000
I70.11 Atherosclerosis of renal artery (with gangrene)	0.001	0.999	0.000
M81.99 Osteoporosis, unspecified (Site unspecified)	0.000	0.999	0.001
S02.00 Fracture of vault of skull (closed)	0.001	0.999	0.000
D44.3 Pituitary gland	0.001	0.999	0.000
D86.0 Sarcoidosis of lung	0.001	0.999	0.000
H11.3 Conjunctival haemorrhage	0.000	0.999	0.001
I65.0 Occlusion and stenosis of vertebral artery	0.000	0.999	0.001
S99.9 Unspecified injury of ankle and foot	0.001	0.999	0.000
W17.6 Industrial and construction area	0.001	0.999	0.000
Z99 Dependence on enabling machines and devices, not elsewhere classified	0.000	0.999	0.001
M13.93 Arthritis, unspecified (Forearm)	0.000	0.999	0.001
M46.09 Spinal enthesopathy (Site unspecified)	0.000	0.999	0.001
M46.08 Spinal enthesopathy (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M46.07 Spinal enthesopathy (Lumbosacral region)	0.000	0.999	0.001
M46.06 Spinal enthesopathy (Lumbar region)	0.000	0.999	0.001
M46.05 Spinal enthesopathy (Thoracolumbar region)	0.000	0.999	0.001
M46.04 Spinal enthesopathy (Thoracic region)	0.000	0.999	0.001
M46.03 Spinal enthesopathy (Cervicothoracic region)	0.000	0.999	0.001
M46.02 Spinal enthesopathy (Cervical region)	0.000	0.999	0.001
M46.01 Spinal enthesopathy (Occipito-atlanto-axial region)	0.000	0.999	0.001
M46.00 Spinal enthesopathy (Multiple sites in spine)	0.000	0.999	0.001
M46.29 Osteomyelitis of vertebra (Site unspecified)	0.000	0.999	0.001
M46.28 Osteomyelitis of vertebra (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M46.27 Osteomyelitis of vertebra (Lumbosacral region)	0.000	0.999	0.001
M46.26 Osteomyelitis of vertebra (Lumbar region)	0.000	0.999	0.001
M46.25 Osteomyelitis of vertebra (Thoracolumbar region)	0.000	0.999	0.001
M46.24 Osteomyelitis of vertebra (Thoracic region)	0.000	0.999	0.001
M46.23 Osteomyelitis of vertebra (Cervicothoracic region)	0.000	0.999	0.001
M46.22 Osteomyelitis of vertebra (Cervical region)	0.000	0.999	0.001
M46.21 Osteomyelitis of vertebra (Occipito-atlanto-axial region)	0.000	0.999	0.001
M46.20 Osteomyelitis of vertebra (Multiple sites in spine)	0.000	0.999	0.001
M46.59 Other infective spondylopathies (Site unspecified)	0.000	0.999	0.001
M46.58 Other infective spondylopathies (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M46.57 Other infective spondylopathies (Lumbosacral region)	0.000	0.999	0.001
M46.56 Other infective spondylopathies (Lumbar region)	0.000	0.999	0.001
M46.55 Other infective spondylopathies (Thoracolumbar region)	0.000	0.999	0.001
M46.54 Other infective spondylopathies (Thoracic region)	0.000	0.999	0.001
M46.53 Other infective spondylopathies (Cervicothoracic region)	0.000	0.999	0.001
M46.52 Other infective spondylopathies (Cervical region)	0.000	0.999	0.001
M46.51 Other infective spondylopathies (Occipito-atlanto-axial region)	0.000	0.999	0.001
M46.50 Other infective spondylopathies (Multiple sites in spine)	0.000	0.999	0.001
M46.89 Other specified inflammatory spondylopathies (Site unspecified)	0.000	0.999	0.001
M46.88 Other specified inflammatory spondylopathies (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M46.87 Other specified inflammatory spondylopathies (Lumbosacral region)	0.000	0.999	0.001
M46.86 Other specified inflammatory spondylopathies (Lumbar region)	0.000	0.999	0.001
M46.85 Other specified inflammatory spondylopathies (Thoracolumbar region)	0.000	0.999	0.001
M46.84 Other specified inflammatory spondylopathies (Thoracic region)	0.000	0.999	0.001
M46.83 Other specified inflammatory spondylopathies (Cervicothoracic region)	0.000	0.999	0.001
M46.82 Other specified inflammatory spondylopathies (Cervical region)	0.000	0.999	0.001
M46.81 Other specified inflammatory spondylopathies (Occipito-atlanto-axial region)	0.000	0.999	0.001
M46.80 Other specified inflammatory spondylopathies (Multiple sites in spine)	0.000	0.999	0.001
D44.6 Carotid body	0.001	0.999	0.000
D69.3 Idiopathic thrombocytopenic purpura	0.000	0.999	0.001
L50.1 Idiopathic urticaria	0.001	0.999	0.000
O20.0 Threatened abortion	0.000	0.999	0.001
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.999	0.001
W11.6 Industrial and construction area	0.001	0.999	0.000
W17.5 Trade and service area	0.001	0.999	0.000
Z99.9 Dependence on unspecified enabling machine and device	0.000	0.999	0.001
Z99.4 Dependence on artificial heart	0.000	0.999	0.001
Z99.0 Dependence on aspirator	0.000	0.999	0.001
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.999	0.001
M46.19 Sacroiliitis, not elsewhere classified-Site unspe	0.000	0.999	0.001
M46.17 Sacroiliitis, not elsewhere classified-Lumbosacral	0.000	0.999	0.001
M46.16 Sacroiliitis, not elsewhere classified-Lumbar	0.000	0.999	0.001
M46.15 Sacroiliitis, not elsewhere classified-Thoracolumbar	0.000	0.999	0.001
M46.14 Sacroiliitis, not elsewhere classified-Thoracic	0.000	0.999	0.001
M46.13 Sacroiliitis, not elsewhere classified-Cervicothoracic	0.000	0.999	0.001
M46.12 Sacroiliitis, not elsewhere classified-Cervical	0.000	0.999	0.001
M46.11 Sacroiliitis, not elsewhere classified-Occipit-atl-axl	0.000	0.999	0.001
M46.10 Sacroiliitis, not elsewhere classified-Mult site	0.000	0.999	0.001
M65.43 Radial styloid tenosynovitis [de Quervain] (Forearm)	0.001	0.999	0.000
S42.40 Fracture of lower end of humerus (closed)	0.001	0.999	0.000
C49.3 Connective and soft tissue of thorax	0.000	0.999	0.001
C49.0 Connective and soft tissue of head, face and neck	0.000	0.999	0.001
D59.1 Other autoimmune haemolytic anaemias	0.000	0.999	0.001
F40.8 Other phobic anxiety disorders	0.000	0.999	0.001
F40.1 Social phobias	0.000	0.999	0.001
G40.9 Epilepsy, unspecified	0.001	0.999	0.000
I22.8 Subsequent myocardial infarction of other sites	0.001	0.999	0.000
M24.1 Other articular cartilage disorders	0.000	0.999	0.001
M46.3 Infection of intervertebral disk (pyogenic)	0.000	0.999	0.001
M46.1 Sacro-iliitis, not elsewhere classified	0.000	0.999	0.001
F40 Phobic anxiety disorders	0.000	0.999	0.001
R44 Other symptoms and signs involving general sensations and perceptions	0.001	0.999	0.000
M24.19 Other articular cartilage disorders (Site unspecified)	0.000	0.999	0.001
M24.18 Other articular cartilage disorders (Other)	0.000	0.999	0.001
M24.14 Other articular cartilage disorders (Hand)	0.000	0.999	0.001
M24.12 Other articular cartilage disorders (Upper arm)	0.000	0.999	0.001
M24.10 Other articular cartilage disorders (Multiple sites)	0.000	0.999	0.001
M46.39 Infection of intervertebral disc (pyogenic) (Site unspecified)	0.000	0.999	0.001
M46.38 Infection of intervertebral disc (pyogenic) (Sacral and sacrococcygeal region)	0.000	0.999	0.001
M46.37 Infection of intervertebral disc (pyogenic) (Lumbosacral region)	0.000	0.999	0.001
M46.35 Infection of intervertebral disc (pyogenic) (Thoracolumbar region)	0.000	0.999	0.001
M46.34 Infection of intervertebral disc (pyogenic) (Thoracic region)	0.000	0.999	0.001
M46.33 Infection of intervertebral disc (pyogenic) (Cervicothoracic region)	0.000	0.999	0.001
M46.32 Infection of intervertebral disc (pyogenic) (Cervical region)	0.000	0.999	0.001
M46.31 Infection of intervertebral disc (pyogenic) (Occipito-atlanto-axial region)	0.000	0.999	0.001
M46.30 Infection of intervertebral disc (pyogenic) (Multiple sites in spine)	0.000	0.999	0.001
M84.13 Nonunion of fracture [pseudarthrosis] (Forearm)	0.000	0.999	0.001
F31.8 Other bipolar affective disorders	0.000	0.999	0.001
F31.6 Bipolar affective disorder, current episode mixed	0.000	0.999	0.001
S80.8 Other superficial injuries of lower leg	0.000	0.999	0.001
W17.4 Street and highway	0.001	0.999	0.000
W17.3 Sports and athletics area	0.001	0.999	0.000
F31 Bipolar affective disorder	0.000	0.999	0.001
A63.8 Other specified predominantly sexually transmitted diseases	0.000	0.999	0.001
C46.9 Kaposi's sarcoma, unspecified	0.000	0.999	0.001
C46.8 Kaposi's sarcoma of multiple organs	0.000	0.999	0.001
C46.7 Kaposi's sarcoma of other sites	0.000	0.999	0.001
C46.3 Kaposi's sarcoma of lymph nodes	0.000	0.999	0.001

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations